Using amyloid PET and tau PET with ¹⁸F-florzolotau, researchers demonstrated that patients with late-onset psychosis (LOP) exhibit significantly higher rates of both amyloid (35% vs 2%) and tau (65% vs 15%) positivity than controls. Various tau accumulation patterns observed in patients indicate that LOP may constitute a prodromal phase of diverse neurodegenerative disorders.